Vis enkel innførsel

dc.contributor.authorThorkildsen, Marianne Thorkildsen
dc.contributor.authorGustad, Lise Tuset
dc.contributor.authorMohus, Randi Marie
dc.contributor.authorBurgess, Stephen
dc.contributor.authorNilsen, Tom Ivar Lund
dc.contributor.authorDamås, Jan Kristian
dc.contributor.authorRogne, Tormod
dc.date.accessioned2023-11-17T10:33:01Z
dc.date.available2023-11-17T10:33:01Z
dc.date.created2023-10-31T10:54:12Z
dc.date.issued2023
dc.identifier.issn2168-6238
dc.identifier.urihttps://hdl.handle.net/11250/3103173
dc.description.abstractImportance Insomnia has been associated with altered inflammatory response as well as increased risk of infections and sepsis in observational studies. However, these studies are prone to bias, such as residual confounding. To further understand the potential causal association between insomnia and sepsis risk, a 2-sample Mendelian randomization (MR) approach should be explored. Objective To evaluate whether genetically predicted insomnia is associated with risk of sepsis. Design, Setting, and Participants Two-sample MR was performed to estimate the association between genetically predicted insomnia and sepsis risk. Data were obtained from a genome-wide association study identifying 555 independent genetic variants (R2 < 0.01) strongly associated with insomnia (P < 5 × 10−8). Sensitivity analyses were conducted to address bias due to pleiotropy and sample overlap, along with mediation analyses and sex-stratified analyses. The insomnia data set included 2.4 million individuals of European ancestry from the UK Biobank and 23andMe. For sepsis, 462 918 individuals of European ancestry from the UK Biobank were included. Data were extracted between February and December 2022 and analyzed between March 2022 and March 2023. Exposure Genetically predicted insomnia. Main Outcome and Measure Sepsis. Results There were 593 724 individuals with insomnia and 10 154 cases of sepsis. A doubling in the population prevalence of genetically predicted insomnia was associated with an odds ratio of 1.37 (95% CI, 1.19-1.57; P = 7.6 × 10−6) for sepsis. Sensitivity analyses supported this observation. One-third of the association between genetically predicted insomnia and risk of sepsis was mediated through a combination of cardiometabolic risk factors for sepsis (body mass index, type 2 diabetes, smoking, or cardiovascular disease; overall proportion, 35.2%; 95% CI, 5.1-76.9). The association between insomnia and sepsis was more pronounced among women compared with men (women: odds ratio, 1.44; 95% CI, 1.24-1.68; men: OR, 1.10; 95% CI, 0.86-1.40). Conclusions and Relevance The concordance between these findings and previous observational studies supports that insomnia is potentially causally associated with the risk of sepsis. Thus, insomnia is a potential preventable risk factor of sepsis that should be further investigated, also in non-European populations.en_US
dc.language.isoengen_US
dc.publisherJAMA Psychiatryen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAssociation of Genetically Predicted Insomnia with Risk of Sepsis: A Mendelian Randomization Studyen_US
dc.title.alternativeAssociation of Genetically Predicted Insomnia with Risk of Sepsis: A Mendelian Randomization Studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber1061-1065en_US
dc.source.volume80en_US
dc.source.journalJAMA psychiatryen_US
dc.source.issue10en_US
dc.identifier.doi10.1001/jamapsychiatry.2023.2717
dc.identifier.cristin2190391
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal